High mortality due to cutaneous melanoma in Norway: a study of prognostic factors in a nationwide cancer registry

References

• ForseaAMDel MarmolVde VriesEBaileyEEGellerACMelanoma incidence and mortality in Europe: new estimates, persistent disparitiesBr J Dermatol201216751124113022759278
   PubMed Web of Science ®Google Scholar
• Cancer Registry of NorwayCancer in Norway 2016 – Cancer Incidence, Mortality, Survival and Prevalence in NorwayOsloCancer Registry of Norway2017
   Google Scholar
• BalchCMGershenwaldJESoongSJFinal version of 2009 AJCC melanoma staging and classificationJ Clin Oncol200927366199620619917835
   PubMed Web of Science ®Google Scholar
• ScolyerRAJudgeMJEvansAInternational Collaboration on Cancer ReportingData set for pathology reporting of cutaneous invasive melanoma: recommendations from the international collaboration on cancer reporting (ICCR)Am J Surg Pathol201337121797181424061524
   PubMed Web of Science ®Google Scholar
• AminMBGreeneFLEdgeSBThe eighth edition AJCC cancer staging manual: continuing to build a bridge from a population-based to a more “personalized” approach to cancer stagingCA Cancer J Clin2017672939928094848
   PubMed Web of Science ®Google Scholar
• TryggvadóttirLGislumMHakulinenTTrends in the survival of patients diagnosed with malignant melanoma of the skin in the Nordic countries 1964–2003 followed up to the end of 2006Acta Oncol201049566567220491525
   PubMed Web of Science ®Google Scholar
• LythJErikssonHHanssonJTrends in cutaneous malignant melanoma in Sweden 1997–2011: thinner tumours and improved survival among menBr J Dermatol2015172370070625323770
   PubMed Web of Science ®Google Scholar
• BayCKejsAMStormHHEngholmGIncidence and survival in patients with cutaneous melanoma by morphology, anatomical site and TNM stage: a Danish Population-Based Register study 1989–2011Cancer Epidemiol20153911725468643
   PubMed Web of Science ®Google Scholar
• RobsahmTEBergvaGHestvikUEMollerBSex differences in rising trends of cutaneous malignant melanoma in Norway, 1954–2008Melanoma Res2013231707823222548
   PubMed Web of Science ®Google Scholar
• AutierPKoechlinABoniolMThe forthcoming inexorable decline of cutaneous melanoma mortality in light-skinned populationsEur J Cancer201551786987825771950
   PubMed Web of Science ®Google Scholar
• WeyersWThe ’epidemic’ of melanoma between under- and overdiagnosisJ Cutan Pathol201239191622211330
   PubMed Web of Science ®Google Scholar
• LarsenIKSmastuenMJohannesenTBData quality at the Cancer Registry of Norway: an overview of comparability, completeness, validity and timelinessEur J Cancer20094571218123119091545
   PubMed Web of Science ®Google Scholar
• World Health OrganizationInternational Classification of Diseases for OncologyThird Edition First Revision edGenevaWorld Health Organization2013
   Google Scholar
• The National Guidelines for Diagnosis, Treatment and Follow-Up of Malignant MelanomasNorwegian: Directorate of Health Available from: https://helsedirektoratet.no/retningslinjer/nasjonalt-handlings-program-med-retningslinjer-for-diagnostikk-behandling-og-oppfol-ging-av-maligne-melanomerAccessed September 1, 2017
   Google Scholar
• AndersenPKGeskusRBde WitteTPutterHCompeting risks in epidemiology: possibilities and pitfallsInt J Epidemiol201241386187022253319
   PubMed Web of Science ®Google Scholar
• SatagopanJMBen-PoratLBerwickMRobsonMKutlerDAuerbachADA note on competing risks in survival data analysisBr J Cancer20049171229123515305188
   PubMed Web of Science ®Google Scholar
• PintilieMAn introduction to competing risks analysisRev Esp Cardiol201164759960521621892
   PubMed Web of Science ®Google Scholar
• KhosrotehraniKDasguptaPByromLYouldenDRBaadePDGreenACMelanoma survival is superior in females across all tumour stages but is influenced by ageArch Dermatol Res20153071873174026103951
   PubMed Web of Science ®Google Scholar
• WhiteIRRoystonPWoodAMMultiple imputation using chained equations: issues and guidance for practiceStat Med201130437739921225900
   PubMed Web of Science ®Google Scholar
• LindholmCAnderssonRDufmatsMSwedish Melanoma Study GroupInvasive cutaneous malignant melanoma in Sweden, 1990–1999. A prospective, population-based study of survival and prognostic factorsCancer200410192067207815372475
   PubMed Web of Science ®Google Scholar
• GarbeCMcLeodGRBuettnerPGTime trends of cutaneous melanoma in Queensland, Australia and Central EuropeCancer20008961269127811002222
   PubMed Web of Science ®Google Scholar
• CriscioneVDWeinstockMAMelanoma thickness trends in the United States, 1988–2006J Invest Dermatol2010130379379719829301
   PubMed Web of Science ®Google Scholar
• BaadePMengXYouldenDAitkenJYoulPTime trends and latitudinal differences in melanoma thickness distribution in Australia, 1990–2006Int J Cancer2012130117017821344376
   PubMed Web of Science ®Google Scholar
• KruijffSBastiaannetEFranckenABSchaapveldMvan der AaMHoekstraHJBreslow thickness in the Netherlands: a population-based study of 40 880 patients comparing young and elderly patientsBr J Cancer2012107357057422713665
   PubMed Web of Science ®Google Scholar
• ShaikhWRDuszaSWWeinstockMAOliveriaSAGellerACHalpernACMelanoma thickness and survival trends in the United States, 1989 to 2009J Natl Cancer Inst20151081djv29426563354
   PubMedGoogle Scholar
• LasithiotakisKLeiterUMeierFAge and gender are significant independent predictors of survival in primary cutaneous melanomaCancer200811281795180418306371
   PubMed Web of Science ®Google Scholar
• MagnusKThe Nordic profile of skin cancer incidence. A comparative epidemiological study of the three main types of skin cancerInt J Cancer199147112191985867
   PubMed Web of Science ®Google Scholar
• BalchCMSoongSRossMILong-term results of a multi-institutional randomized trial comparing prognostic factors and surgical results for intermediate thickness melanomas (1.0 to 4.0 mm). Inter-group Melanoma Surgical TrialAnn Surg Oncol200072879710761786
   PubMed Web of Science ®Google Scholar
• JimenezREPanageasKBusamKJBradyMSPrognostic implications of multiple lymphatic basin drainage in patients with truncal melanomaJ Clin Oncol200523351852415659497
   PubMed Web of Science ®Google Scholar
• ShaikhWRWeinstockMAHalpernACOliveriaSAGellerACDuszaSWThe characterization and potential impact of melanoma cases with unknown thickness in the United States’ Surveillance, Epidemiology, and End Results Program, 1989–2008Cancer Epidemiol2013371647022995853
   PubMed Web of Science ®Google Scholar
• Månsson-BrahmeEJohanssonHSingnomklaoTLarsonORutquistLERingborgUTime Trends in Survival in Cutaneous Malignant Melanoma; a Population-Based Study in SwedenCutaneous Malignant Melanoma. Aspects on Prognostical Factors and Time-Trends in a Swedish Population [thesis]. Paper ll128StockholmKarolinska University Press2002
   Google Scholar
• WhitemanDCBaadePDOlsenCMMore people die from thin melanomas (1 mm) than from thick melanomas (>4 mm) in Queensland, AustraliaJ Invest Dermatol201513541190119325330295
   PubMed Web of Science ®Google Scholar
• ShaikhWRXiongMWeinstockMAThe contribution of nodular subtype to melanoma mortality in the United States, 1978 to 2007Arch Dermatol20121481303621931016
   PubMedGoogle Scholar
• MarVRobertsHWolfeREnglishDRKellyJWNodular melanoma: a distinct clinical entity and the largest contributor to melanoma deaths in Victoria, AustraliaJ Am Acad Dermatol201368456857523182058
   PubMed Web of Science ®Google Scholar
• ErikssonHFrohm-NilssonMJarasJPrognostic factors in localized invasive primary cutaneous malignant melanoma: results of a large population-based studyBr J Dermatol2015172117518624910143
   PubMed Web of Science ®Google Scholar
• CicchielloMLinMJPanYMcLeanCKellyJWAn assessment of clinical pathways and missed opportunities for the diagnosis of nodular melanoma versus superficial spreading melanomaAustralas J Dermatol20165729710126563931
   PubMed Web of Science ®Google Scholar
• LinMJMarVMcLeanCWolfeRKellyJWDiagnostic accuracy of malignant melanoma according to subtypeAustralas J Dermatol2014551354224283461
   PubMed Web of Science ®Google Scholar
• McGovernTWLitakerMSClinical predictors of malignant pigmented lesions. A comparison of the Glasgow seven-point checklist and the American Cancer Society’s ABCDs of pigmented lesionsJ Dermatol Surg Oncol199218122261740563
   PubMedGoogle Scholar
• LiuWDowlingJPMurrayWKRate of growth in melanomas: characteristics and associations of rapidly growing melanomasArch Dermatol2006142121551155817178980
   PubMed Web of Science ®Google Scholar
• RobsahmTEKaragasMRReesJRSyseANew malignancies after squamous cell carcinoma and melanomas: a population-based study from NorwayBMC Cancer20141421024645632
   PubMed Web of Science ®Google Scholar
• RoweCJLawMHPalmerJMMacGregorSHaywardNKKhosrotehraniKSurvival outcomes in patients with multiple primary melanomasJ Eur Acad Dermatol Venereol201529112120212725864459
   PubMed Web of Science ®Google Scholar
• ThøgersenHMøllerBRobsahmTEAaserudSBabigumiraRLarsenIKComparison of cancer stage distribution in the immigrant and host populations of Norway, 1990–2014Int J Cancer20171411526128369751
   PubMed Web of Science ®Google Scholar